Fourth quarter 2014 IBO Life Science Index sales grew 7.3%, 9.0% organically, to $4,317 million, marking its strongest organic growth since the first quarter of 2010. Growth was driven by demand from US pharmaceutical and biotechnology customers, increased research spending in Europe and positive demand in China. However, delayed spending in Japan and weak academic […]
Washington, DC 3/3/15—OpGen has filed for an IPO of its common stock on the NASDAQ Stock Market. OpGen provides the Acuitas multidrug-resistant organism (MDRO)–focused products for rapidly identifying infections in hospital patients and the Argus Whole Genome Mapping system. In 2014, sales increased 71.1% to $4.1 million (see page 12) due to increased collaboration revenue. […]
Global equity markets rebounded sharply in February, as a number of international indexes traded at multiyear or record highs due to continued accommodative monetary policies and a temporary financial rescue of Greece. US markets were supported by positive corporate earnings and reassurance by the Federal Reserve of maintaining low interest rates. US fourth quarter 2014 […]
Hong Kong 12/15/14; Hong Kong 12/29/14; Hong Kong 1/19/15—Shanghai-based BBI Life Sciences, a provider of life science–research products and services, has completed a public offering of its common stock on the Hong Kong Stock Exchange. The company offered 91,815,000 shares at a price of HKD 1.75 per share ($0.23 = HKD 7.76 = $1) on […]
Despite improvements in the US and China and in pharmaceutical and academic markets, currency effects curtailed sales and profit growth for major publicly held instrument and laboratory-product businesses in the fourth quarter of 2014. For the year, the businesses maintained revenue growth, helped by pharmaceutical sales and improved academic markets. Combined sales for the six […]
The companies listed below—Danaher, FEI, Hitachi High-Technologies and Mettler-Toledo—are major providers of analytical instrumentation and laboratory products but are excluded from IBO’s Laboratory Instrument Sales Index due to their reporting format. Thus, the financial results for the fourth quarter and year-end 2014 for these companies are presented below. Fourth quarter 2014 sales for Danaher’s Life […]
With fewer than half the IBO Laboratory Instrument Index companies reporting quarterly results before this issue’s publication, IBO estimates fourth quarter 2014 sales for the Index improved roughly 5%–6% organically. Operating profit for the Index is expected to have advanced 8%. Operating profit margin is projected to have climbed roughly 250 basis points to more […]
Columbia, MD 2/5/15—W R Grace & Co. announced that it plans to separate into two publicly traded companies. Grace’s Discovery Sciences business will join “New Grace,” which is comprised of the Catalysts Technologies and Materials Technologies segments. Grace’s Construction Products and Darex packaging business will comprise “New GCP.” The separation is expected to be completed […]
Company Announcements Bruker announced on its third quarter 2014 conference call that its divestiture of certain GC and GC/MS assets (see IBO 10/15/14) and its ICP-MS (see IBO 8/15/14) business generated approximately $28 million in proceeds. As part of the CAM restructuring, Bruker is relocating GC triple-quadrupole MS manufacturing from Fremont, California, to Bremen, Germany, […]
Since IBO’s recent article on 2015 economic forecasts (see IBO 1/15/15), the International Monetary Fund (IMF) has issued a revision of its October 2014 “World Economic Outlook.” According to the update, which was released earlier this month, the factors influencing the change are the drop in oil prices, the economic downturn in major economies other […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
